Revenue FY2025
$872.0M
Net Income
$2.0M
EPS (Basic)
$0.01
Net Margin
0.2%
ROE
0.4%
Total Equity
$368.0M
Shares Out
113M
Warby Parker Inc. — Ophthalmic Goods. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2019–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 8 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Durable Capital Partners
Henry Ellenbogen
$194.1M
1.1%
—
SRS Investment Management
SRS Investment Management
$44.1M
0.3%
+1.0%
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$72.7M
0.2%
+3.6%
Atreides Management
Atreides Management
$21.2M
0.2%
+1.7%
Motley Fool Asset Management
Motley Fool Asset Management
$1.8M
0.1%
+59.2%
Gardner Russo & Quinn
Thomas Russo
$2.4M
0.0%
—
First Eagle Investment Management
First Eagle
$8.7M
0.0%
+113.2%
Capital World Investors
Capital World Investors
$44.4M
0.0%
+7.3%
Insider Transactions
Reading stored insider transactions…